

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.54968336 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.54968336 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28555461 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.28555461 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.82703249 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.23781999 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.23781999 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.23781999 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.05324748 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.03672999 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.00166350 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.86816971 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.81688369 |
| 14 | cysteine metabolic process (GO:0006534) | 5.75010751 |
| 15 | proline metabolic process (GO:0006560) | 5.58448346 |
| 16 | protein-lipid complex assembly (GO:0065005) | 5.51993971 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.51812092 |
| 18 | urea cycle (GO:0000050) | 5.51574167 |
| 19 | urea metabolic process (GO:0019627) | 5.51574167 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.46711865 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.43741131 |
| 22 | intestinal cholesterol absorption (GO:0030299) | 5.40155667 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35639141 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.31901276 |
| 25 | protein carboxylation (GO:0018214) | 5.28063319 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.28063319 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.27360349 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.23500264 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.15932872 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.07294900 |
| 31 | homocysteine metabolic process (GO:0050667) | 5.00606104 |
| 32 | lysine metabolic process (GO:0006553) | 5.00256416 |
| 33 | lysine catabolic process (GO:0006554) | 5.00256416 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.99574140 |
| 35 | bile acid metabolic process (GO:0008206) | 4.96956336 |
| 36 | regulation of complement activation (GO:0030449) | 4.89828995 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89408965 |
| 38 | plasma lipoprotein particle organization (GO:0071827) | 4.78201920 |
| 39 | proline biosynthetic process (GO:0006561) | 4.75784834 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.72722176 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.68962909 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.67376425 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.65528036 |
| 44 | glycine metabolic process (GO:0006544) | 4.62537112 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.57735097 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.57735097 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.57099270 |
| 48 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.56637175 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.55120446 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.50322866 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.50322866 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.50322866 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.49909232 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.49909232 |
| 55 | protein-lipid complex subunit organization (GO:0071825) | 4.49887857 |
| 56 | serine family amino acid metabolic process (GO:0009069) | 4.49564003 |
| 57 | regulation of plasminogen activation (GO:0010755) | 4.41517111 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 4.39366575 |
| 59 | indolalkylamine metabolic process (GO:0006586) | 4.37827601 |
| 60 | glutamate metabolic process (GO:0006536) | 4.36546593 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.33750727 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.32570367 |
| 63 | regulation of apoptotic cell clearance (GO:2000425) | 4.27616339 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 4.26934937 |
| 65 | amine catabolic process (GO:0009310) | 4.26934937 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 4.25892087 |
| 67 | phospholipid efflux (GO:0033700) | 4.24611845 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.23377169 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.21978414 |
| 70 | drug catabolic process (GO:0042737) | 4.20465160 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 4.20426171 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.18791489 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 4.17302120 |
| 74 | cellular glucuronidation (GO:0052695) | 4.14997803 |
| 75 | intestinal absorption (GO:0050892) | 4.05502855 |
| 76 | ethanol oxidation (GO:0006069) | 4.05015377 |
| 77 | urate metabolic process (GO:0046415) | 4.04618333 |
| 78 | fibrinolysis (GO:0042730) | 3.97761952 |
| 79 | arginine metabolic process (GO:0006525) | 3.95205586 |
| 80 | cholesterol efflux (GO:0033344) | 3.94877059 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.94793451 |
| 82 | aldehyde catabolic process (GO:0046185) | 3.92663961 |
| 83 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.89266320 |
| 84 | drug transmembrane transport (GO:0006855) | 3.86004646 |
| 85 | ketone body metabolic process (GO:1902224) | 3.78577416 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.78244288 |
| 87 | organic acid catabolic process (GO:0016054) | 3.76948542 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.76948542 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.76640576 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.70983200 |
| 91 | glucuronate metabolic process (GO:0019585) | 3.70737611 |
| 92 | uronic acid metabolic process (GO:0006063) | 3.70737611 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.69820871 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69160356 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69160356 |
| 96 | exogenous drug catabolic process (GO:0042738) | 3.68019637 |
| 97 | sterol homeostasis (GO:0055092) | 3.66401825 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.64867419 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.64094246 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.63200330 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.62468442 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59511648 |
| 103 | cofactor catabolic process (GO:0051187) | 3.56955949 |
| 104 | complement activation (GO:0006956) | 3.56067795 |
| 105 | positive regulation of lipid catabolic process (GO:0050996) | 3.55442455 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55297080 |
| 107 | 2-oxoglutarate metabolic process (GO:0006103) | 3.53299025 |
| 108 | regulation of cholesterol metabolic process (GO:0090181) | 3.52398877 |
| 109 | protein activation cascade (GO:0072376) | 3.52124283 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.52056194 |
| 111 | cytolysis (GO:0019835) | 3.51570528 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.50908042 |
| 113 | positive regulation of steroid metabolic process (GO:0045940) | 3.48669155 |
| 114 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.46715521 |
| 115 | * regulation of cholesterol homeostasis (GO:2000188) | 3.46598876 |
| 116 | positive regulation of hormone metabolic process (GO:0032352) | 3.40328714 |
| 117 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.39764839 |
| 118 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.39655183 |
| 119 | L-serine metabolic process (GO:0006563) | 3.36910900 |
| 120 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.30695213 |
| 121 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.29149996 |
| 122 | 4-hydroxyproline metabolic process (GO:0019471) | 3.25761896 |
| 123 | diacylglycerol metabolic process (GO:0046339) | 3.25649564 |
| 124 | negative regulation of blood coagulation (GO:0030195) | 3.20246111 |
| 125 | negative regulation of hemostasis (GO:1900047) | 3.20246111 |
| 126 | sterol transport (GO:0015918) | 3.17265709 |
| 127 | cholesterol transport (GO:0030301) | 3.17265709 |
| 128 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.15705718 |
| 129 | acute-phase response (GO:0006953) | 3.11416793 |
| 130 | epoxygenase P450 pathway (GO:0019373) | 3.07430843 |
| 131 | lipid homeostasis (GO:0055088) | 3.00919729 |
| 132 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.97073886 |
| 133 | negative regulation of coagulation (GO:0050819) | 2.96329264 |
| 134 | ethanol metabolic process (GO:0006067) | 2.95275049 |
| 135 | negative regulation of protein activation cascade (GO:2000258) | 2.87390134 |
| 136 | regulation of lipoprotein particle clearance (GO:0010984) | 2.82883761 |
| 137 | negative regulation of wound healing (GO:0061045) | 2.81720559 |
| 138 | positive regulation of hemostasis (GO:1900048) | 2.81559228 |
| 139 | positive regulation of blood coagulation (GO:0030194) | 2.81559228 |
| 140 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.81421096 |
| 141 | negative regulation of lipid transport (GO:0032369) | 2.78796354 |
| 142 | cellular zinc ion homeostasis (GO:0006882) | 2.77743791 |
| 143 | * regulation of bile acid biosynthetic process (GO:0070857) | 2.74208352 |
| 144 | vitamin transmembrane transport (GO:0035461) | 2.73078842 |
| 145 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.72887860 |
| 146 | basement membrane organization (GO:0071711) | 2.72301390 |
| 147 | low-density lipoprotein particle clearance (GO:0034383) | 2.70147007 |
| 148 | glutamine family amino acid catabolic process (GO:0009065) | 2.68222328 |
| 149 | fatty acid homeostasis (GO:0055089) | 2.66887097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30377744 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21191150 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.57148227 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41837776 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.09734087 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89821241 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.87365065 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08386218 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78569659 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.21331268 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18721926 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15346953 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11042104 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07127652 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7935659 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99170253 |
| 17 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.83535439 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70270039 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63204100 |
| 20 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56615631 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53108761 |
| 22 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50603609 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46156208 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44751277 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42786968 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41442146 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40902518 |
| 28 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.39459214 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38932745 |
| 30 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38656343 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33715697 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33677290 |
| 33 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33273516 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32715532 |
| 35 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31079703 |
| 36 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.30042299 |
| 37 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29108199 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25423521 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24970463 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24430104 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23198303 |
| 42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22737633 |
| 43 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.22303336 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21743890 |
| 45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21417502 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21396522 |
| 47 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.20873575 |
| 48 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.20360961 |
| 49 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20359920 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.19936884 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19675826 |
| 52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19117892 |
| 53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18888317 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.17862177 |
| 55 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16962760 |
| 56 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16282961 |
| 57 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16070676 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13224306 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11531348 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.11332956 |
| 61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10010212 |
| 62 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09890380 |
| 63 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.07320837 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07319750 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06708364 |
| 66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06658202 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06106619 |
| 68 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05103213 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04509486 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01220195 |
| 71 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01059466 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00988236 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.00305941 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99962257 |
| 75 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98948173 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98130502 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.97451718 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96862380 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95435352 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.95173650 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94129451 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91577026 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90600229 |
| 84 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90086870 |
| 85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89463808 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88958448 |
| 87 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83779902 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82864921 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80456624 |
| 90 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79420585 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78167470 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.77387007 |
| 93 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75986228 |
| 94 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75949306 |
| 95 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73243403 |
| 96 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71259208 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70447060 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.69820632 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.67691237 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66038676 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64968758 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.63035429 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62924016 |
| 104 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.62484171 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61513628 |
| 106 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59972113 |
| 107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59000561 |
| 108 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.58980661 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58077086 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57543731 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56923986 |
| 112 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.56821331 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55929973 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55500311 |
| 115 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55416359 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.55023648 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53752225 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53752225 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52227755 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51853616 |
| 121 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51612495 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.51435012 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51210108 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50819441 |
| 125 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.49852396 |
| 126 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49138244 |
| 127 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48198716 |
| 128 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.46169909 |
| 129 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46123299 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.46068698 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.45751380 |
| 132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.44878285 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44489988 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44172001 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.43943074 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.43394926 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.42983594 |
| 138 | CBP_21632823_ChIP-Seq_H3396_Human | 0.42847198 |
| 139 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42599086 |
| 140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42197600 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.41738996 |
| 142 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41554503 |
| 143 | ATF3_27146783_Chip-Seq_COLON_Human | 0.41483401 |
| 144 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41378531 |
| 145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40738047 |
| 146 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.40329058 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39693433 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.39674024 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39260060 |
| 150 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38828345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25976955 |
| 2 | MP0005360_urolithiasis | 7.72315443 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.16428239 |
| 4 | MP0005365_abnormal_bile_salt | 5.96260500 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92820897 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.06407186 |
| 7 | MP0000566_synostosis | 4.03474639 |
| 8 | MP0003252_abnormal_bile_duct | 3.95170058 |
| 9 | MP0003122_maternal_imprinting | 3.63414323 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.41983871 |
| 11 | MP0009840_abnormal_foam_cell | 3.26829293 |
| 12 | MP0005332_abnormal_amino_acid | 2.97279542 |
| 13 | MP0005083_abnormal_biliary_tract | 2.95018504 |
| 14 | MP0003195_calcinosis | 2.88245892 |
| 15 | MP0003123_paternal_imprinting | 2.62508754 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.59774056 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.46794088 |
| 18 | MP0002089_abnormal_postnatal_growth/wei | 2.43734417 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.40056011 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.32154433 |
| 21 | MP0000609_abnormal_liver_physiology | 2.08968797 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.00442554 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.82959558 |
| 24 | MP0003868_abnormal_feces_composition | 1.73107403 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.72335681 |
| 26 | MP0003941_abnormal_skin_development | 1.65038309 |
| 27 | MP0004272_abnormal_basement_membrane | 1.59883556 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.59467770 |
| 29 | MP0001764_abnormal_homeostasis | 1.52536621 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.49928568 |
| 31 | MP0005451_abnormal_body_composition | 1.49310054 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48655976 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.47533671 |
| 34 | MP0005257_abnormal_intraocular_pressure | 1.42098370 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.30317384 |
| 36 | MP0003115_abnormal_respiratory_system | 1.29778634 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.27476214 |
| 38 | MP0009697_abnormal_copulation | 1.23101496 |
| 39 | MP0003186_abnormal_redox_activity | 1.22528364 |
| 40 | MP0003011_delayed_dark_adaptation | 1.19281611 |
| 41 | MP0003121_genomic_imprinting | 1.17061159 |
| 42 | MP0000598_abnormal_liver_morphology | 1.17044561 |
| 43 | MP0001915_intracranial_hemorrhage | 1.16754398 |
| 44 | MP0003942_abnormal_urinary_system | 1.16595881 |
| 45 | MP0001849_ear_inflammation | 1.13447471 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.11599979 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.08876758 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.08622434 |
| 49 | MP0001730_embryonic_growth_arrest | 1.07830863 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.07219682 |
| 51 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06391591 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.05871980 |
| 53 | MP0002697_abnormal_eye_size | 1.02525530 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.02316837 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 0.99845996 |
| 56 | MP0005647_abnormal_sex_gland | 0.99425224 |
| 57 | MP0004858_abnormal_nervous_system | 0.97551008 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 0.96943644 |
| 59 | MP0003878_abnormal_ear_physiology | 0.96943644 |
| 60 | MP0001346_abnormal_lacrimal_gland | 0.93703282 |
| 61 | MP0002938_white_spotting | 0.93623603 |
| 62 | MP0009764_decreased_sensitivity_to | 0.92612213 |
| 63 | MP0003315_abnormal_perineum_morphology | 0.92427727 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 0.91766459 |
| 65 | MP0000003_abnormal_adipose_tissue | 0.91419995 |
| 66 | MP0009763_increased_sensitivity_to | 0.90988853 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.90934970 |
| 68 | MP0003119_abnormal_digestive_system | 0.90875067 |
| 69 | MP0004233_abnormal_muscle_weight | 0.90367781 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 0.89979994 |
| 71 | MP0003890_abnormal_embryonic-extraembry | 0.89526051 |
| 72 | MP0000537_abnormal_urethra_morphology | 0.88275228 |
| 73 | MP0000604_amyloidosis | 0.88234445 |
| 74 | MP0001756_abnormal_urination | 0.88020110 |
| 75 | MP0005409_darkened_coat_color | 0.87607306 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.87266397 |
| 77 | MP0002254_reproductive_system_inflammat | 0.86644271 |
| 78 | MP0009642_abnormal_blood_homeostasis | 0.83926216 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 0.81202252 |
| 80 | MP0008469_abnormal_protein_level | 0.80131795 |
| 81 | MP0005408_hypopigmentation | 0.79602420 |
| 82 | MP0009053_abnormal_anal_canal | 0.79115073 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.76096312 |
| 84 | MP0004133_heterotaxia | 0.75562898 |
| 85 | MP0003943_abnormal_hepatobiliary_system | 0.75442184 |
| 86 | MP0001672_abnormal_embryogenesis/_devel | 0.73973451 |
| 87 | MP0005380_embryogenesis_phenotype | 0.73973451 |
| 88 | MP0002909_abnormal_adrenal_gland | 0.73924818 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.73285002 |
| 90 | MP0001661_extended_life_span | 0.72537745 |
| 91 | MP0003111_abnormal_nucleus_morphology | 0.72446781 |
| 92 | MP0003984_embryonic_growth_retardation | 0.71840698 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.70141050 |
| 94 | MP0002092_abnormal_eye_morphology | 0.69477385 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.69205382 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.69186149 |
| 97 | MP0000462_abnormal_digestive_system | 0.69142425 |
| 98 | MP0001286_abnormal_eye_development | 0.68393816 |
| 99 | MP0002971_abnormal_brown_adipose | 0.68203031 |
| 100 | MP0001697_abnormal_embryo_size | 0.67907455 |
| 101 | MP0005670_abnormal_white_adipose | 0.67819143 |
| 102 | MP0002928_abnormal_bile_duct | 0.67213464 |
| 103 | MP0004270_analgesia | 0.65763437 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.65667216 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.65291163 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.62296226 |
| 107 | MP0005379_endocrine/exocrine_gland_phen | 0.61750560 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.61677558 |
| 109 | MP0002233_abnormal_nose_morphology | 0.61562356 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.61277339 |
| 111 | MP0002098_abnormal_vibrissa_morphology | 0.61133797 |
| 112 | MP0002080_prenatal_lethality | 0.60678985 |
| 113 | MP0005334_abnormal_fat_pad | 0.60358280 |
| 114 | MP0009703_decreased_birth_body | 0.60266420 |
| 115 | MP0004197_abnormal_fetal_growth/weight/ | 0.59890746 |
| 116 | MP0005395_other_phenotype | 0.59888993 |
| 117 | MP0005266_abnormal_metabolism | 0.57406010 |
| 118 | MP0004130_abnormal_muscle_cell | 0.54228950 |
| 119 | MP0003718_maternal_effect | 0.53636552 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.52234194 |
| 121 | MP0005535_abnormal_body_temperature | 0.52147920 |
| 122 | MP0003329_amyloid_beta_deposits | 0.51599732 |
| 123 | MP0002796_impaired_skin_barrier | 0.48886649 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.48542464 |
| 125 | MP0004264_abnormal_extraembryonic_tissu | 0.48312208 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.48256054 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.48118717 |
| 128 | MP0009672_abnormal_birth_weight | 0.47423806 |
| 129 | MP0004043_abnormal_pH_regulation | 0.47163124 |
| 130 | MP0005448_abnormal_energy_balance | 0.45244887 |
| 131 | MP0002168_other_aberrant_phenotype | 0.45207461 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.43570586 |
| 133 | MP0010234_abnormal_vibrissa_follicle | 0.42499282 |
| 134 | MP0003690_abnormal_glial_cell | 0.42235221 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.40709158 |
| 136 | MP0005666_abnormal_adipose_tissue | 0.40052405 |
| 137 | MP0002060_abnormal_skin_morphology | 0.39658017 |
| 138 | MP0000579_abnormal_nail_morphology | 0.38572089 |
| 139 | MP0001243_abnormal_dermal_layer | 0.38193523 |
| 140 | MP0003953_abnormal_hormone_level | 0.37436466 |
| 141 | MP0008873_increased_physiological_sensi | 0.36294174 |
| 142 | MP0002135_abnormal_kidney_morphology | 0.36005315 |
| 143 | MP0005248_abnormal_Harderian_gland | 0.35841034 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.33994518 |
| 145 | MP0002269_muscular_atrophy | 0.33654889 |
| 146 | MP0003075_altered_response_to | 0.32300680 |
| 147 | MP0005166_decreased_susceptibility_to | 0.32253768 |
| 148 | MP0003300_gastrointestinal_ulcer | 0.31743135 |
| 149 | MP0003724_increased_susceptibility_to | 0.31526740 |
| 150 | MP0009115_abnormal_fat_cell | 0.31465670 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.30253820 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.28703166 |
| 153 | MP0008874_decreased_physiological_sensi | 0.28294474 |
| 154 | MP0005023_abnormal_wound_healing | 0.27551594 |
| 155 | MP0004883_abnormal_blood_vessel | 0.27459878 |
| 156 | MP0000249_abnormal_blood_vessel | 0.27301641 |
| 157 | MP0003453_abnormal_keratinocyte_physiol | 0.26944282 |
| 158 | MP0002970_abnormal_white_adipose | 0.26749224 |
| 159 | MP0008872_abnormal_physiological_respon | 0.25841569 |
| 160 | MP0000538_abnormal_urinary_bladder | 0.25619764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23397142 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.22937587 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.04753423 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.52006001 |
| 5 | Xanthomatosis (HP:0000991) | 6.19173783 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.04297326 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.98021901 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.22171332 |
| 9 | Complement deficiency (HP:0004431) | 5.14173221 |
| 10 | Hyperglycinemia (HP:0002154) | 4.79029484 |
| 11 | Hyperammonemia (HP:0001987) | 4.59891451 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.58787063 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.53975260 |
| 14 | Hyperglycinuria (HP:0003108) | 4.47688266 |
| 15 | Joint hemorrhage (HP:0005261) | 4.45452138 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.31358669 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31358669 |
| 18 | Ketosis (HP:0001946) | 4.26354496 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25618148 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22390200 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.13515648 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.12226355 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.07320889 |
| 24 | Epidermoid cyst (HP:0200040) | 4.06982044 |
| 25 | Fat malabsorption (HP:0002630) | 3.99830434 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.92088379 |
| 27 | Abnormality of complement system (HP:0005339) | 3.87203511 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.77551994 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.69409533 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56943422 |
| 31 | Gout (HP:0001997) | 3.52869988 |
| 32 | Asymmetry of the thorax (HP:0001555) | 3.48640573 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.46631907 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39342525 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.33771566 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29161139 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.17980689 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17704336 |
| 39 | Ketoacidosis (HP:0001993) | 3.12622886 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.11536583 |
| 41 | Hyperbilirubinemia (HP:0002904) | 3.09669833 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 3.09036942 |
| 43 | Myocardial infarction (HP:0001658) | 3.07317559 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 3.06703295 |
| 45 | Steatorrhea (HP:0002570) | 3.00147318 |
| 46 | Spontaneous abortion (HP:0005268) | 2.85576208 |
| 47 | Vaginal fistula (HP:0004320) | 2.77238134 |
| 48 | Metabolic acidosis (HP:0001942) | 2.77138877 |
| 49 | Vascular calcification (HP:0004934) | 2.76353143 |
| 50 | Flat acetabular roof (HP:0003180) | 2.73773748 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.68242287 |
| 52 | Hepatoblastoma (HP:0002884) | 2.67754116 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64704739 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.64704739 |
| 55 | Lethargy (HP:0001254) | 2.63386140 |
| 56 | Malnutrition (HP:0004395) | 2.62812438 |
| 57 | Abnormality of carpal bone ossification (HP:0006257) | 2.62669693 |
| 58 | Bronchomalacia (HP:0002780) | 2.57794777 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.56303157 |
| 60 | Skin nodule (HP:0200036) | 2.54845828 |
| 61 | Spastic diplegia (HP:0001264) | 2.52529903 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.49468776 |
| 63 | Pterygium (HP:0001059) | 2.48027147 |
| 64 | Mitral stenosis (HP:0001718) | 2.46028355 |
| 65 | Neonatal onset (HP:0003623) | 2.44499852 |
| 66 | Abnormal tarsal ossification (HP:0008369) | 2.43203746 |
| 67 | Broad alveolar ridges (HP:0000187) | 2.42907301 |
| 68 | Esophageal varix (HP:0002040) | 2.42682103 |
| 69 | Irritability (HP:0000737) | 2.38602609 |
| 70 | Enlarged kidneys (HP:0000105) | 2.33175374 |
| 71 | Late onset (HP:0003584) | 2.32936814 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.30885331 |
| 73 | Hyperuricemia (HP:0002149) | 2.28557583 |
| 74 | Increased purine levels (HP:0004368) | 2.28557583 |
| 75 | Glomerulonephritis (HP:0000099) | 2.27933067 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.25870176 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.25870176 |
| 78 | Bifid scrotum (HP:0000048) | 2.24603712 |
| 79 | Abnormal gallbladder morphology (HP:0012437) | 2.22924464 |
| 80 | Popliteal pterygium (HP:0009756) | 2.21681390 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.21011981 |
| 82 | Cholelithiasis (HP:0001081) | 2.20473052 |
| 83 | Proximal tubulopathy (HP:0000114) | 2.19698616 |
| 84 | Alkalosis (HP:0001948) | 2.16787927 |
| 85 | Choanal stenosis (HP:0000452) | 2.16775032 |
| 86 | Small epiphyses (HP:0010585) | 2.16423937 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.15701967 |
| 88 | Cerebral edema (HP:0002181) | 2.14269042 |
| 89 | Rickets (HP:0002748) | 2.14228394 |
| 90 | Acanthocytosis (HP:0001927) | 2.13665327 |
| 91 | Osteomalacia (HP:0002749) | 2.12321980 |
| 92 | Pancreatitis (HP:0001733) | 2.10230052 |
| 93 | Vomiting (HP:0002013) | 2.09971533 |
| 94 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.08919632 |
| 95 | Amyloidosis (HP:0011034) | 2.08474624 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.08230831 |
| 97 | Thrombophlebitis (HP:0004418) | 2.03717795 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.03145170 |
| 99 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01001441 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.99868696 |
| 101 | Abnormal gallbladder physiology (HP:0012438) | 1.99265503 |
| 102 | Cholecystitis (HP:0001082) | 1.99265503 |
| 103 | Brushfield spots (HP:0001088) | 1.98143242 |
| 104 | Abnormal ossification of hand bones (HP:0005921) | 1.97360677 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.94950380 |
| 106 | Widely patent fontanelles and sutures (HP:0004492) | 1.93613623 |
| 107 | Malignant hyperthermia (HP:0002047) | 1.93314278 |
| 108 | Menorrhagia (HP:0000132) | 1.92527593 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 1.91375239 |
| 110 | Glycosuria (HP:0003076) | 1.91375239 |
| 111 | Gingival bleeding (HP:0000225) | 1.89931397 |
| 112 | Broad palm (HP:0001169) | 1.89604681 |
| 113 | Opisthotonus (HP:0002179) | 1.89356750 |
| 114 | Abnormality of glycolysis (HP:0004366) | 1.87893724 |
| 115 | Hyperglycemia (HP:0003074) | 1.86990217 |
| 116 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86520919 |
| 117 | Abnormality of the nasal septum (HP:0000419) | 1.86074252 |
| 118 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.85202455 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 1.85123789 |
| 120 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84923638 |
| 121 | Alacrima (HP:0000522) | 1.84752704 |
| 122 | Potter facies (HP:0002009) | 1.84076298 |
| 123 | Facial shape deformation (HP:0011334) | 1.84076298 |
| 124 | Abnormality of iron homeostasis (HP:0011031) | 1.83411246 |
| 125 | Abnormal hand bone ossification (HP:0010660) | 1.82950613 |
| 126 | Lymphangioma (HP:0100764) | 1.82446608 |
| 127 | Neonatal death (HP:0003811) | 1.81009443 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.79625560 |
| 129 | Impaired pain sensation (HP:0007328) | 1.79299503 |
| 130 | Abnormality of pain sensation (HP:0010832) | 1.79299503 |
| 131 | Abnormal delivery (HP:0001787) | 1.78608191 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.78136101 |
| 133 | Partial duplication of thumb phalanx (HP:0009944) | 1.77946189 |
| 134 | Abnormality of the lacrimal duct (HP:0011481) | 1.76095683 |
| 135 | Renal duplication (HP:0000075) | 1.73760352 |
| 136 | Abnormality of the lumbar spine (HP:0100712) | 1.70689469 |
| 137 | Ulnar bowing (HP:0003031) | 1.70034026 |
| 138 | Abnormality of the vitreous humor (HP:0004327) | 1.67087512 |
| 139 | Pigmentary retinal degeneration (HP:0001146) | 1.66979588 |
| 140 | Wide cranial sutures (HP:0010537) | 1.65896901 |
| 141 | Diastasis recti (HP:0001540) | 1.65242973 |
| 142 | Septate vagina (HP:0001153) | 1.63499698 |
| 143 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.61379683 |
| 144 | Renovascular hypertension (HP:0100817) | 1.61074343 |
| 145 | Overlapping toe (HP:0001845) | 1.58290526 |
| 146 | Back pain (HP:0003418) | 1.56821879 |
| 147 | Biconcave vertebral bodies (HP:0004586) | 1.56200652 |
| 148 | Akinesia (HP:0002304) | 1.55375015 |
| 149 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.55059670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.03154089 |
| 2 | ERN1 | 4.57770066 |
| 3 | SIK1 | 4.42275649 |
| 4 | SMG1 | 3.22746162 |
| 5 | EEF2K | 3.09942662 |
| 6 | ERBB4 | 2.85193147 |
| 7 | TRIB3 | 2.69063296 |
| 8 | CDK12 | 2.60454044 |
| 9 | TAOK3 | 2.57299117 |
| 10 | MST1R | 2.53481539 |
| 11 | PKN2 | 2.32049402 |
| 12 | LATS1 | 2.29220740 |
| 13 | INSRR | 2.26124887 |
| 14 | TYRO3 | 1.96557914 |
| 15 | PTK6 | 1.89649761 |
| 16 | MAPK11 | 1.80840425 |
| 17 | STK38L | 1.69665534 |
| 18 | MAP2K4 | 1.68510417 |
| 19 | EPHA2 | 1.62741458 |
| 20 | PIK3CG | 1.57570061 |
| 21 | EPHB1 | 1.55476047 |
| 22 | CDK7 | 1.52963771 |
| 23 | LMTK2 | 1.50443546 |
| 24 | FLT3 | 1.46539148 |
| 25 | NEK9 | 1.44615838 |
| 26 | ABL2 | 1.41142638 |
| 27 | RIPK1 | 1.35968485 |
| 28 | TYK2 | 1.32550682 |
| 29 | EPHA3 | 1.29551059 |
| 30 | * FGFR4 | 1.25641390 |
| 31 | MAP3K3 | 1.24925681 |
| 32 | MAP3K10 | 1.24581189 |
| 33 | MAP3K7 | 1.24561603 |
| 34 | RPS6KB2 | 1.24527252 |
| 35 | FRK | 1.21661948 |
| 36 | MAP2K3 | 1.20242039 |
| 37 | KDR | 1.19179452 |
| 38 | FGFR2 | 1.18775025 |
| 39 | TTK | 1.17467584 |
| 40 | MET | 1.16038299 |
| 41 | PBK | 1.15393659 |
| 42 | MAPK15 | 1.14093354 |
| 43 | ERBB2 | 1.11067077 |
| 44 | MUSK | 1.08707644 |
| 45 | DAPK2 | 1.08448294 |
| 46 | NME1 | 1.08329334 |
| 47 | WNK4 | 1.07818156 |
| 48 | WNK3 | 1.07337446 |
| 49 | PTK2 | 1.06072640 |
| 50 | TIE1 | 1.04787708 |
| 51 | GRK6 | 1.04786979 |
| 52 | JAK2 | 1.04273339 |
| 53 | PRKAA2 | 0.99313556 |
| 54 | PINK1 | 0.98796062 |
| 55 | DYRK1B | 0.97935382 |
| 56 | CDK6 | 0.97390548 |
| 57 | MAPKAPK3 | 0.96344773 |
| 58 | PIK3CA | 0.95106076 |
| 59 | GSK3A | 0.91900410 |
| 60 | BRSK1 | 0.91156387 |
| 61 | PRKG2 | 0.89325447 |
| 62 | MAP3K11 | 0.87022437 |
| 63 | PRKCI | 0.85457746 |
| 64 | TGFBR2 | 0.84801131 |
| 65 | PRKCZ | 0.84609952 |
| 66 | MTOR | 0.80635965 |
| 67 | STK39 | 0.78420197 |
| 68 | TBK1 | 0.77973121 |
| 69 | JAK1 | 0.77104880 |
| 70 | NEK2 | 0.75221478 |
| 71 | MATK | 0.75088470 |
| 72 | MAPK4 | 0.73640984 |
| 73 | RET | 0.72270355 |
| 74 | PRKAA1 | 0.71550461 |
| 75 | MAP2K6 | 0.69930091 |
| 76 | CDK4 | 0.69700767 |
| 77 | DDR2 | 0.68601905 |
| 78 | BRD4 | 0.66376683 |
| 79 | MAP2K2 | 0.66312351 |
| 80 | LATS2 | 0.64400735 |
| 81 | CSNK1E | 0.64042479 |
| 82 | CAMK2G | 0.63880879 |
| 83 | BRSK2 | 0.63423523 |
| 84 | PRKACG | 0.63006705 |
| 85 | TSSK6 | 0.62408705 |
| 86 | SGK3 | 0.61873194 |
| 87 | MAP2K1 | 0.61514741 |
| 88 | CSK | 0.60480570 |
| 89 | FGFR3 | 0.59602048 |
| 90 | PDK3 | 0.58577583 |
| 91 | PDK4 | 0.58577583 |
| 92 | MAPK12 | 0.58078234 |
| 93 | AKT3 | 0.57633732 |
| 94 | FER | 0.57038824 |
| 95 | NME2 | 0.56790647 |
| 96 | BMX | 0.56471984 |
| 97 | CDK8 | 0.54882105 |
| 98 | NEK1 | 0.53670060 |
| 99 | EPHB2 | 0.52360031 |
| 100 | TAOK2 | 0.51971446 |
| 101 | MAP3K9 | 0.51950574 |
| 102 | OXSR1 | 0.51829460 |
| 103 | PDPK1 | 0.51108699 |
| 104 | ICK | 0.50652003 |
| 105 | RPS6KB1 | 0.49066793 |
| 106 | IRAK3 | 0.48118251 |
| 107 | PDGFRA | 0.48085013 |
| 108 | CDC42BPA | 0.47563098 |
| 109 | STK3 | 0.47269419 |
| 110 | OBSCN | 0.45867962 |
| 111 | MAP3K14 | 0.45789935 |
| 112 | CDK1 | 0.45133012 |
| 113 | CAMK1D | 0.43189049 |
| 114 | PASK | 0.43118529 |
| 115 | ALK | 0.42633978 |
| 116 | CSNK1G1 | 0.42218394 |
| 117 | BUB1 | 0.41179409 |
| 118 | RPS6KA1 | 0.40661791 |
| 119 | PDK2 | 0.40162387 |
| 120 | SGK494 | 0.39794302 |
| 121 | SGK223 | 0.39794302 |
| 122 | MAP3K2 | 0.39027131 |
| 123 | CHEK1 | 0.38568235 |
| 124 | MAP3K8 | 0.37975249 |
| 125 | CDK15 | 0.37809961 |
| 126 | DAPK1 | 0.37710321 |
| 127 | FGFR1 | 0.37349013 |
| 128 | CDC7 | 0.37188202 |
| 129 | CDK2 | 0.36142829 |
| 130 | SGK2 | 0.35492213 |
| 131 | CHEK2 | 0.35389490 |
| 132 | VRK2 | 0.35314520 |
| 133 | CDK11A | 0.35022380 |
| 134 | GRK1 | 0.34371748 |
| 135 | SRPK1 | 0.33593201 |
| 136 | MAPK7 | 0.33391914 |
| 137 | CDK18 | 0.32927072 |
| 138 | PLK1 | 0.32051604 |
| 139 | AKT2 | 0.31333627 |
| 140 | RPS6KA2 | 0.30978301 |
| 141 | CSNK2A2 | 0.29072295 |
| 142 | CHUK | 0.28940773 |
| 143 | NTRK1 | 0.28371679 |
| 144 | EIF2AK1 | 0.28186844 |
| 145 | IGF1R | 0.28161645 |
| 146 | CSNK2A1 | 0.27742794 |
| 147 | GSK3B | 0.27718081 |
| 148 | MAP3K5 | 0.26663647 |
| 149 | MAPK14 | 0.26485341 |
| 150 | SCYL2 | 0.26395616 |
| 151 | MAP3K1 | 0.25396797 |
| 152 | CSNK1D | 0.25114988 |
| 153 | AURKB | 0.24599484 |
| 154 | PAK4 | 0.24505235 |
| 155 | STK38 | 0.24268938 |
| 156 | EGFR | 0.23741557 |
| 157 | PAK3 | 0.23695240 |
| 158 | CDK9 | 0.22539543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33822616 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48699935 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41338412 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27451960 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99432114 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81420153 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70292851 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65716724 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.65149640 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53526025 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50499747 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44378724 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32361955 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23995340 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.07448672 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05177390 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94790006 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88938415 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86455356 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84684343 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83934511 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83031750 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78618658 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76693728 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73024498 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70816323 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68387816 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66154488 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65912337 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65609332 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64477535 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58451775 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.55696969 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53350369 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49904138 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49118484 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41195619 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37393543 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37111625 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36443751 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32305006 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32005165 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.27288438 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26084823 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25328123 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20210199 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19550052 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18976863 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14799486 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14086716 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13764339 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.11431326 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07278727 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05962378 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03863332 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03605659 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97308231 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94598182 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.90847913 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89209575 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79651501 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78624642 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77094479 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74010553 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73289801 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68684528 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63659350 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60066917 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59787778 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46408687 |
| 71 | Tight junction_Homo sapiens_hsa04530 | 0.46145349 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43934500 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40634582 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39586336 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.36639889 |
| 76 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.33141903 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31136520 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29497107 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.29244283 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27898919 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.25598778 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24650148 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23559352 |
| 84 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.21983376 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21962184 |
| 86 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.21699342 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.19975350 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.18693426 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17285096 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17167265 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15272146 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07014966 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04455734 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2016321 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1963355 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1799494 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1792632 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | -0.1707694 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1601117 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.1450407 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | -0.1385068 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1355256 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1332448 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1286546 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1279454 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | -0.1155799 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1087680 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1056508 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0972791 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0906906 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0683418 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0471680 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0177696 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0156290 |

